Related Experiment Videos
Mitotic signaling by beta-amyloid causes neuronal death
A Copani1, F Condorelli, A Caruso
1Biochemistry and. Pharmacology, School of Medicine, University of Catania, Italy.
Summary
Beta-amyloid peptide (betaAP) aggregates, found in Alzheimer's disease, trigger neuronal proliferation by initiating the cell cycle. Inhibiting key cell cycle proteins prevents betaAP-induced neuronal death, suggesting therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Alzheimer's Disease Research
Background:
- Alzheimer's disease is characterized by beta-amyloid peptide (betaAP) plaques that induce neuronal death via unknown mechanisms.
- Beta-amyloid aggregates are implicated in the pathogenesis of Alzheimer's disease.
Purpose of the Study:
- To elucidate the mechanism by which beta-amyloid peptide aggregates cause neuronal death.
- To investigate the role of cell cycle regulation in beta-amyloid-induced neurotoxicity.
Main Methods:
- Treatment of differentiated cortical neurons with full-length betaAP and its active fragment betaAP(25-35).
- Analysis of cell cycle progression markers, including cyclin D1, retinoblastoma phosphorylation, and cyclins E and A.
- Inhibition of cyclin-dependent protein kinases 4 and 2 to assess their role in apoptosis.
Main Results:
- Beta-amyloid peptide fragments induced neuronal proliferation and entry into the cell cycle.
- Neuronal cell cycle progression was arrested at the S phase.
- Inhibition of cyclin-dependent protein kinases 4/2 blocked both S phase entry and apoptosis in betaAP-treated neurons.
Conclusions:
- Neuronal death induced by beta-amyloid peptide requires progression through the G1/S phase transition.
- The cell cycle pathway represents a potential target for neuroprotective strategies against Alzheimer's disease.